Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimers disease and diabetes
Often referred to as an exercise mimetic in preclinical research, SLU-PP-332 has gained significant interest within the scientific community due to its interaction with estrogen-related receptors (ERRs), which play a role in cellular energy production and mitochondrial function
A great example of the innovation driven by members of the Eurobiomed community and the SKIN Excellence initiative, which brings together researchers, clinicians and industry to accelerate innovation in skin health
Here are five GLP-1 programs worth knowing about in 2026, ranked with the strongest overall option first
Compounded medications are prepared by state-licensed pharmacies when a licensed prescriber determines a customized formulation, dosage, or strength is appropriate for an individual patient, or when a commercially available product is unavailable